[Remote] MRD Clinical Account Executive, Northern California at Tempus

California, United States

Tempus Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Biotechnology, Medical Devices, PharmaceuticalsIndustries

Requirements

Candidates should possess a B.S. in life science, biology, business, or marketing, with an MBA preferred. A proven track record of revenue generation in diagnostics, pharmaceuticals, or biotechnology is essential, along with at least 3 years of direct account management experience in molecular diagnostics, ideally with a focus on MRD testing. Experience working with major cancer centers, oncology GPOs, large health systems, and oncology practices is required. The role demands proven ability to sell integrated molecular diagnostic solutions and engage in consultative selling, comfort in interacting with executive-level stakeholders, and an in-depth understanding of the payer and reimbursement environment in oncology diagnostics. Strong independent work ethic with excellent communication, project management, and prioritization skills, combined with knowledge of molecular diagnostics, MRD testing, and the competitive landscape in oncology, are necessary. Proficiency in Microsoft Office (Excel, PowerPoint) and Salesforce.com, along with the ability to develop cross-functional relationships, advanced presentation skills, business acumen, and the capacity to work effectively with minimal direction, are also required.

Responsibilities

The MRD Clinical Account Executive is responsible for driving the adoption of Tempus's MRD testing services within their assigned territory, which includes major U.S. cancer centers, health systems, and community practices. This involves engaging with Key Opinion Leaders (KOLs), clinicians, and decision-makers to establish and expand business opportunities, and developing strategic plans for acquiring new clients and retaining existing ones while maximizing client-bill contracting opportunities. The role includes implementing laboratory services agreements (LSAs) for client billing, collaborating with various sales roles within Tempus to achieve company goals, and identifying/developing partnership opportunities between oncology clients and Tempus to promote MRD testing integration. The executive will provide feedback to Tempus leadership based on market analysis and competitive landscape, and develop and implement a comprehensive business plan for the territory, including budgets, travel, territory management, and goal setting. They will also represent Tempus's company culture with integrity, respect, and trust to all stakeholders.

Skills

Precision Medicine
Healthcare Industry
AI in Clinical Care
Real-world Evidence
Actionable Insights
MRD Testing
Business Development
Sales
Client Acquisition
Client Retention
Laboratory Services Agreements (LSAs)
Partnership Development
Market Analysis
Competitive Landscape
Territory Management
Budgeting
Goal Setting
Integrity
Respect
Trust

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters
2015Year Founded
$894.9MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Relocation Assistance
Company Equity
Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.
Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.
Their platform aids in personalized treatment decisions for cancer patients.
Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI